Back to search

The use of antidepressants in novel combination therapies.

Data up to Jan 2025

Published2003
Citations33
References35

Total Citations Per Year

Abstract

References (35)

Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder

1991 • 1,896 citations

A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression

2000 • 1,296 citations

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis

2002 • 544 citations

A Novel Augmentation Strategy for Treating Resistant Major Depression

2001 • 513 citations

Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis

2002 • 512 citations

Estrogen Therapy for Severe Persistent Depressions in Women

1979 • 356 citations

Treatment options for refractory depression.

1999 • 317 citations

Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies

1999 • 304 citations

A Preliminary, Open Study of the Combination of Fluoxetine and Desipramine for Rapid Treatment of Major Depression

1991 • 303 citations

A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression

1993 • 267 citations

Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression

1999 • 249 citations

Response and Remission Rates in Different Subpopulations With Major Depressive Disorder Administered Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Placebo

2001 • 245 citations

Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex

2000 • 231 citations

Comparison of Desipramine and Cognitive/Behavioral Therapy in the Treatment of Elderly Outpatients With Mild-to-Moderate Depression

2001 • 199 citations

Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.

1991 • 170 citations

A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients

1996 • 168 citations

Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression

2000 • 168 citations

Risperidone in the treatment of affective illness and obsessive-compulsive disorder.

1995 • 165 citations

Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors

2001 • 146 citations

Clozapine in the treatment of dysphoric mania

1992 • 126 citations

Combination Treatment with Noradrenalin and Serotonin Reuptake Inhibitors in Resistant Depression

1992 • 121 citations

Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.

1989 • 121 citations

CNS Stimulant Potentiation of Monoamine Oxidase

1991 • 116 citations

An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.

1993 • 111 citations

Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression

2001 • 111 citations

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

1995 • 104 citations

Lithium Augmentation in Antidepressant-Resistant Patients a Quantitative Analysis

1991 • 99 citations

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure

2001 • 96 citations

Possible augmentation of antidepressant response by buspirone.

1991 • 84 citations

Clozapine in the Treatment of Psychotic Refractory Depression

1993 • 48 citations

Vagus nerve stimulation in depression

2001 • 46 citations

Improvement of depression following transcranial magnetic stimulation

1999 • 40 citations

Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.

1995 • 31 citations

Lithium augmentation of antidepressants in treatment-refractory depression.

1998 • 29 citations

Olanzapine-fluoxetine combination in treatment-resistant depression

2002 • 13 citations

Cited By (0)

Loading...